131 related articles for article (PubMed ID: 35316310)
1. Ginsenoside Rk1 regulates glutamine metabolism in hepatocellular carcinoma through inhibition of the ERK/c-Myc pathway.
Lu H; Yin H; Qu L; Ma X; Fu R; Fan D
Food Funct; 2022 Apr; 13(7):3793-3811. PubMed ID: 35316310
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK/mTOR signaling pathway.
Wu H; Qu L; Bai X; Zhu C; Liu Y; Duan Z; Liu H; Fu R; Fan D
Food Chem Toxicol; 2024 Apr; 186():114587. PubMed ID: 38461953
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of the ginsenoside Rk1 in human hepatocellular carcinoma cells through inhibition of telomerase activity and induction of apoptosis.
Kim YJ; Kwon HC; Ko H; Park JH; Kim HY; Yoo JH; Yang HO
Biol Pharm Bull; 2008 May; 31(5):826-30. PubMed ID: 18451501
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Tumor Effect and Underlying Apoptotic Mechanism of Ginsenoside Rk1 and Rg5 in Human Liver Cancer Cells.
Chen C; Lv Q; Li Y; Jin YH
Molecules; 2021 Jun; 26(13):. PubMed ID: 34199025
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
Hong Y; Fan D
Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
[TBL] [Abstract][Full Text] [Related]
6. Autophagy inhibition enhances apoptosis induced by ginsenoside Rk1 in hepatocellular carcinoma cells.
Ko H; Kim YJ; Park JS; Park JH; Yang HO
Biosci Biotechnol Biochem; 2009 Oct; 73(10):2183-9. PubMed ID: 19809182
[TBL] [Abstract][Full Text] [Related]
7. Desmocollin-2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma via the ERK/c-MYC signaling pathway.
He B; Guo L; Hu Y; Huang H; Wan L; Xu K; Wang F; Wen Z
Aging (Albany NY); 2022 Nov; 14(21):8805-8817. PubMed ID: 36367775
[TBL] [Abstract][Full Text] [Related]
8. Canagliflozin reduces chemoresistance in hepatocellular carcinoma through PKM2-c-Myc complex-mediated glutamine starvation.
Zeng Y; Jiang H; Zhang X; Xu J; Wu X; Xu Q; Cai W; Ying H; Zhou R; Ding Y; Ying K; Song X; Chen Z; Zeng L; Zhao L; Yu F
Free Radic Biol Med; 2023 Nov; 208():571-586. PubMed ID: 37696420
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.
Lu M; Fei Z; Zhang G
Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
Zhou X; Zhu A; Gu X; Xie G
Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma.
Hu M; Yang J; Qu L; Deng X; Duan Z; Fu R; Liang L; Fan D
Food Funct; 2020 Jan; 11(1):456-471. PubMed ID: 31830168
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg3 Decreases NHE1 Expression via Inhibiting EGF-EGFR-ERK1/2-HIF-1
Li X; Tsauo J; Geng C; Zhao H; Lei X; Li X
Am J Chin Med; 2018; 46(8):1915-1931. PubMed ID: 30525897
[TBL] [Abstract][Full Text] [Related]
13. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
14. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
[TBL] [Abstract][Full Text] [Related]
15. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside exhibits concentration-dependent dual effects on HepG2 cell proliferation via regulation of c-Myc and HNF-4α.
Li Y; Xiao Z; Li B; Liu K; Wang H; Qi J; Wang Y
Eur J Pharmacol; 2016 Dec; 792():26-32. PubMed ID: 27756603
[TBL] [Abstract][Full Text] [Related]
17. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by ginsenoside Rk1 in SK-MEL-2-human melanoma.
Kim JS; Joo EJ; Chun J; Ha YW; Lee JH; Han Y; Kim YS
Arch Pharm Res; 2012 Mar; 35(4):717-22. PubMed ID: 22553065
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rk1 Induces Apoptosis in Neuroblastoma Cells Through Loss of Mitochondrial Membrane Potential and Activation of Caspases.
Oh JM; Lee J; Im WT; Chun S
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862004
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt/mTOR/c-Myc signaling.
Shin N; Lee HJ; Sim DY; Im E; Park JE; Park WY; Cho AR; Shim BS; Kim SH
Phytother Res; 2021 Jul; 35(7):3812-3820. PubMed ID: 33856720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
